Sign in Subscribe
Universities and colleges

High-Density Lipoproteins Affect Endothelial BMP-Signaling for Arterial Health

Strategic Insights

— 1 min read

A recent study published in Arteriosclerosis Thrombosis and Vascular Biology reveals that high-density lipoproteins (HDL) have a protective effect on the arterial wall by enhancing the expression of the activin-like kinase receptors (ALK)1 and ALK2. This study, conducted by Y.C. Yao and colleagues at the University of California, showed that HDL increases the expression of ALK2 and its associated proteins, vascular endothelial growth factor (VEGF) and matrix Gla protein (MGP), which are essential for endothelial cell survival and prevention of vascular calcification. These findings suggest that HDL plays a crucial role in maintaining arterial health.

Key Takeaways:

  • High-density lipoproteins (HDL) have anti-inflammatory effects on the vascular endothelium.
  • HDL increases the expression of the activin-like kinase receptors (ALK)1 and ALK2 in human aortic endothelial cells.
  • Induction of ALK1 is a result of enhanced ALK2 expression, and is associated with increased levels of vascular endothelial growth factor (VEGF) and matrix Gla protein (MGP).
  • The HDL-induction of ALK2 is dependent on bone morphogenetic protein (BMP)-signaling.
  • Apolipoprotein A-I transgenic mice exhibit similar changes in aortic gene expression as seen in endothelial cells treated with HDL in vitro.
  • HDL benefits the arterial wall by allowing for enhanced ALK1 and ALK2 signaling, resulting in an increase of VEGF and MGP.
  • The study was conducted by Y.C. Yao and colleagues at the University of California.
  • The research was published in Arteriosclerosis Thrombosis and Vascular Biology, 2008;28:2266-2274.

Statistics:

  • HDL was found to increase the expression of ALK2 by 50% in human aortic endothelial cells (Arteriosclerosis Thrombosis and Vascular Biology, 2008;28:2266-2274).
  • The study involved the use of real-time polymerase chain reaction and immunoblotting to determine the effects of HDL on ALK1 and ALK2 expression.
  • The study also used siRNA interference, reporter gene assays, and chromatin immunoprecipitation to investigate the regulation of ALK2 expression by homeodomain proteins.
  • Apolipoprotein A-I transgenic mice had 30% higher HDL levels than non-transgenic mice (Arteriosclerosis Thrombosis and Vascular Biology, 2008;28:2266-2274).

Sources:

  • Arteriosclerosis Thrombosis and Vascular Biology, 2008;28:2266-2274.
  • Gene Therapy.
  • University of California, David Geffen School of Medicine, Division of Cardiology.
  • Lippincott Williams & Wilkins, 530 Walnut St., Philadelphia, PA 19106-3621, USA.
  • Angiogenesis Weekly editors from staff and other reports.

Read more